These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 25415546

  • 1. Is Dabigatran As Effective As Warfarin on Cardiac Thrombus in a Patient With Atrial Fibrillation? A Challenging Question.
    Sunbul M, Cincin A, Mammadov C, Mutlu B.
    Am J Ther; 2016; 23(3):e974-6. PubMed ID: 25415546
    [Abstract] [Full Text] [Related]

  • 2. Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study.
    Durães AR, de Souza Roriz P, de Almeida Nunes B, Albuquerque FP, de Bulhões FV, de Souza Fernandes AM, Aras R.
    Drugs R D; 2016 Jun; 16(2):149-54. PubMed ID: 26892845
    [Abstract] [Full Text] [Related]

  • 3. Direct thrombin and factor Xa inhibition for stroke prevention in patients with atrial fibrillation.
    Galanis T, Merli GJ.
    Hosp Pract (1995); 2013 Feb; 41(1):26-36. PubMed ID: 23466965
    [Abstract] [Full Text] [Related]

  • 4. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 5. Outcome of Anticoagulation Therapy of Left Atrial Thrombus or Sludge in Patients With Nonvalvular Atrial Fibrillation or Flutter.
    Yang Y, Du X, Dong J, Ma C.
    Am J Med Sci; 2019 Oct 01; 358(4):273-278. PubMed ID: 31543101
    [Abstract] [Full Text] [Related]

  • 6. Effect of dabigatran on referrals to and switching from warfarin in two academic anticoagulation management services.
    Atay JK, Fanikos J, Barnes GD, Ehle M, Coatney J, Piazza G, Froehlich JB, Goldhaber SZ.
    Am J Cardiol; 2013 Aug 01; 112(3):387-9. PubMed ID: 23647794
    [Abstract] [Full Text] [Related]

  • 7. Dabigatran Therapy Resulting in the Resolution of Rivaroxaban-resistant Left Atrial Appendage Thrombi in Patients with Atrial Fibrillation.
    Watanabe T, Shinoda Y, Ikeoka K, Minamisaka T, Fukuoka H, Inui H, Hoshida S.
    Intern Med; 2017 Aug 01; 56(15):1977-1980. PubMed ID: 28768967
    [Abstract] [Full Text] [Related]

  • 8. Rationale and design of the RE-LATED AF--AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus--Effects of Dabigatran in patients with Atrial Fibrillation.
    Ferner M, Wachtlin D, Konrad T, Deuster O, Meinertz T, von Bardeleben S, Münzel T, Seibert-Grafe M, Breithardt G, Rostock T.
    Clin Res Cardiol; 2016 Jan 01; 105(1):29-36. PubMed ID: 26109251
    [Abstract] [Full Text] [Related]

  • 9. Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.
    Brambatti M, Darius H, Oldgren J, Clemens A, Noack HH, Brueckmann M, Yusuf S, Wallentin L, Ezekowitz MD, Connolly SJ, Healey JS.
    Int J Cardiol; 2015 Oct 01; 196():127-31. PubMed ID: 26093161
    [Abstract] [Full Text] [Related]

  • 10. Dabigatran as an alternative for atrial thrombosis resistant to rivaroxaban: A case report.
    Sun H, Zhao Q, Wang Y, Lakin R, Liu X, Yu M, Yang H, Gao D, Chen W, Gao G, Yan M, He Y, Yang P.
    Medicine (Baltimore); 2018 Dec 01; 97(51):e13623. PubMed ID: 30572474
    [Abstract] [Full Text] [Related]

  • 11. Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use.
    Iyer V, Singh HS, Reiffel JA.
    J Cardiovasc Pharmacol Ther; 2012 Sep 01; 17(3):237-47. PubMed ID: 22388002
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort study.
    Lauffenburger JC, Farley JF, Gehi AK, Rhoney DH, Brookhart MA, Fang G.
    J Am Heart Assoc; 2015 Apr 10; 4(4):. PubMed ID: 25862791
    [Abstract] [Full Text] [Related]

  • 13. [Anticoagulation for patients with non-valvular atrial fibrillation].
    Mizoguchi T, Yasaka M.
    Nihon Rinsho; 2016 Apr 10; 74(4):627-33. PubMed ID: 27333751
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation.
    Del-Carpio Munoz F, Yao X, Abraham NS, Bellolio MF, Rabinstein AA, Asirvatham SJ, McBane RD, Gersh BJ, Shah ND, Noseworthy PA.
    J Am Coll Cardiol; 2016 Jul 05; 68(1):129-31. PubMed ID: 27364057
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
    Larsen TB, Rasmussen LH, Skjøth F, Due KM, Callréus T, Rosenzweig M, Lip GY.
    J Am Coll Cardiol; 2013 Jun 04; 61(22):2264-73. PubMed ID: 23562920
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.